Skip to main content
CG
NASDAQ Finance

Carlyle Seeks Shareholder Approval for Expanded Equity Plan and Elects Directors

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
8
Price
$49.03
Mkt Cap
$17.708B
52W Low
$36.495
52W High
$69.848
Market data snapshot near publication time

summarizeSummary

Carlyle Group seeks shareholder approval to expand its equity incentive plan by 19 million shares, alongside director elections and a say-on-pay vote, while emphasizing its $2.0 billion share repurchase program to manage dilution.


check_boxKey Events

  • Equity Incentive Plan Expansion Proposed

    Shareholders will vote on increasing the share reserve for the 2012 Equity Incentive Plan by an additional 19,000,000 shares, raising the total authorized to 77,800,000. This would make approximately 36,523,587 shares available for future equity grants, representing a significant potential dilutive overhang.

  • Share Repurchase Program Underway

    The company highlights its previously announced $2.0 billion share repurchase authorization (February 26, 2026) as a proactive measure to manage dilution and return capital to shareholders, offsetting some of the potential dilution from the expanded equity plan.

  • Director Elections and Auditor Ratification

    Shareholders will vote on the election of 13 director nominees and the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2026, both routine corporate governance matters.

  • Say-on-Pay Vote for Executive Compensation

    A non-binding advisory vote will be held to approve named executive officer compensation, with CEO Harvey M. Schwartz's 2025 total compensation reported at $7,149,859 and a CEO Pay Ratio of 29:1.


auto_awesomeAnalysis

Carlyle Group Inc. has filed its definitive proxy statement (DEF 14A) for its Annual Meeting on June 3, 2026. A key proposal is the approval of an Amended and Restated 2012 Equity Incentive Plan, which seeks to increase the share reserve by an additional 19,000,000 shares, bringing the total authorized to 77,800,000 shares. If approved, approximately 36,523,587 shares would be available for future grants. This represents a potential dilution of approximately 5.28% from the newly authorized shares and 10.15% if all currently available shares were issued, based on 359,839,214 outstanding shares as of April 6, 2026. The company emphasizes its commitment to managing dilution, noting it achieved effectively 0% dilution in 2025 and has a previously announced $2.0 billion share repurchase program (February 26, 2026) to proactively manage dilution. The filing also includes proposals for the election of 13 directors, the ratification of Ernst & Young LLP as the independent auditor, and a non-binding 'Say-on-Pay' vote for named executive officer compensation. CEO Harvey M. Schwartz's 2025 total compensation was $7,149,859, with a CEO Pay Ratio of 29:1.

At the time of this filing, CG was trading at $49.03 on NASDAQ in the Finance sector, with a market capitalization of approximately $17.7B. The 52-week trading range was $36.50 to $69.85. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CG - Latest Insights

CG
Apr 23, 2026, 4:08 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CG
Apr 09, 2026, 10:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
CG
Mar 31, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
CG
Mar 30, 2026, 2:45 AM EDT
Source: Reuters
Importance Score:
8
CG
Mar 19, 2026, 4:13 PM EDT
Filing Type: 144
Importance Score:
7
CG
Mar 13, 2026, 1:05 AM EDT
Source: Reuters
Importance Score:
7
CG
Mar 02, 2026, 7:04 AM EST
Source: Reuters
Importance Score:
7
CG
Feb 27, 2026, 4:13 PM EST
Filing Type: 10-K
Importance Score:
8
CG
Feb 26, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
9
CG
Feb 05, 2026, 5:39 PM EST
Filing Type: 8-K
Importance Score:
8